Convalescent plasma use in the USA was inversely correlated with COVID-19 mortality

Convalescent plasma use in the USA was inversely correlated with COVID-19 mortality

Background: The US Food and Drug Administration authorized COVID-19 convalescent plasma (CCP) therapy for hospitalized COVID-19 patients via the Expanded Access Program (EAP) and the Emergency Use Authorization (EUA), leading to use in about 500,000 patients during the first year of the pandemic for...

Full description

Bibliographic Details
Main Authors: Arturo Casadevall, Quigly Dragotakes, Patrick W Johnson, Jonathon W Senefeld, Stephen A Klassen, R Scott Wright, Michael J Joyner, Nigel Paneth, Rickey E Carter
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2021-06-01
Series:eLife
Subjects:
COVID
virus infection
convalescent plasma
Online Access:https://elifesciences.org/articles/69866

Internet

https://elifesciences.org/articles/69866

Similar Items